Funding

CND Life Sciences

United States · Biotech

Develops biomarker-based diagnostic tests for neurodegenerative diseases

Visit cndlifesciences.comFunding history

Funding history

1 round · 0 with disclosed amounts
AnnouncedRoundAmountInvestors
GrowthUndisclosedS-Curve Partners — Role not disclosed

Investors

S-Curve PartnersGrowth

Coverage

Aug 4, 2026CND Life Sciences · Growth

Similar companies

Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
iCUREXKagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.¥140M · Series A first close: equity and debt
Sourcescndlifesciences.com ↗